Market revenue in 2023 | USD 552.2 million |
Market revenue in 2030 | USD 1,034.6 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Botulinum toxin |
Fastest growing segment | Hyaluronic Acid |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.82% in 2023. Horizon Databook has segmented the Canada aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s aesthetic injectable market is expected to be driven by the growing number of players entering into strategic partnerships and undertaking novel product launches. For instance, in June 2023, Galderma launched Restylane Eyelight in Canada.
The product aims to correct infraorbital hollowing. Moreover, clinical evidence of the product’s efficacy is expected to propel its adoption across regions. According to the same source, 84% of the patients who received the product made positive statements about it. Nearly 94% of patients said they would recommend the product to acquaintances.
Furthermore, in January 2021, Crescita Therapeutics, Inc. submitted an application to Health Canada for its ART-FILLER injectables product range, which includes five HA-based dermal fillers. The Canadian Association of Medical Spas and Aesthetic Surgeons (CAMACS) recognizes the need for proper guidelines due to the increasing number of cosmetic procedures in nonclinical settings.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into Canada aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account